Robenacoxib
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| IUPAC name
{5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid
|
|
| Identifiers | |
| ChEBI | CHEBI:76269 |
| ChemSpider | 4938295 |
| Jmol 3D model | Interactive image |
| PubChem | 6433107 |
|
|
|
|
| Properties | |
| C16H13F4NO2 | |
| Molar mass | 327.28 g·mol−1 |
| Pharmacology | |
| QM01AH91 (WHO) | |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Robenacoxib (Onsior) is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[1]
References[edit]
- ^ "Onsior (Robenacoxib)". Novartis Animal Health.
|
| This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |

